Pharmaceutical Manufacturing - Real-Time API Quantification and Quality Assessment in a Hot Melt Extrusion
View as a Web Page
News Medical
 
  Pharmaceutical Manufacturing Pharmaceutical Manufacturing logo  
  The latest pharmaceutical manufacturing news from News Medical  
 

Advanced Dissolution Online Testing with precise UV-Vis analysis capabilitiesAdvanced Dissolution Online Testing with precise UV-Vis analysis capabilities

Experience a cutting-edge approach to Dissolution Online Testing with effortless sample transport to your preferred UV-Vis spectrophotometer.

The ERWEKA Dissolution Online System, powered by Disso.NET, delivers precision and automation in online testing.

Streamline Your Lab Workflow
 
 
    Real-Time API Quantification and Quality Assessment in a Hot Melt ExtrusionReal-Time API Quantification and Quality Assessment in a Hot Melt Extrusion
 
Hot Melt Extrusion (HME) is a pivotal pharmaceutical manufacturing technology that enhances drug solubility, availability, and controlled release. Integrating Process Analytical Technology (PAT) in HME processes ensures consistent product quality and process control. This webinar will explore the utilization of Process Raman spectroscopy for real-time quantification and quality assessment of Active Pharmaceutical Ingredients (APIs) during HME.
 
Secure You Spot
 
 
   Chemists Discover Safer Way to Create Powerful Chemical Building BlocksChemists Discover Safer Way to Create Powerful Chemical Building Blocks
 
Chemists have developed a novel way to generate a variety of highly useful chemical building blocks by harnessing metal carbenes, suggests new research.
 
 Elegen and Nutcracker Therapeutics to Pilot First Fully Cell-Free Manufacturing Process for RNA-based Personalized Cancer Therapeutics
 
Elegen and Nutcracker Therapeutics to Pilot First Fully Cell-Free Manufacturing Process for RNA-based Personalized Cancer TherapeuticsElegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry's first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer therapeutics (PCTs).
 
 
 UAB Identifies Six Novel Subsets, Reshaping Immune Knowledge
 
UAB Identifies Six Novel Subsets, Reshaping Immune KnowledgeThe study highlights T-bet's importance in memory B cells, essential for rapid antibody production and sustained immune defense against influenza.
 
 
 Optimal Group joins SciY
 
Optimal Group joins SciYThe SciY business today announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite, creating a single, vendor-agnostic software and automation platform that connects molecular research and development, quality control labs, and full-scale biopharma and specialty chemicals manufacturing environments.
 
 
 Mitigation of β-glucan interference in endotoxin detection
 
Mitigation of β-glucan interference in endotoxin detectionDiscover innovative strategies for mitigating β-glucan interference in endotoxin detection.
 
 
 Liver Organoids for Advancing Disease Research
 
Liver Organoids for Advancing Disease ResearchLearn about the latest advancements in liver organoid technology for advancing disease research.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025